Impact of CPAP on asthmatic patients with obstructive sleep apnoea

European Respiratory Journal

Volumn 29, Issue 2, 2007, Pages 307-311

  Lafond, Chantal ^a,c   Series F ^b   Lemiere C ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c NONE   (Canada)

Author keywords

Airway responsiveness; Asthma; Asthma quality of life; Continuous positive airway pressure; Obstructive sleep apnoea

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHACHOLINE; PREDNISONE; THEOPHYLLINE;

ADULT; AIRWAY DYNAMICS; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAM; ELECTROOCULOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMPEDANCE PLETHYSMOGRAPHY; LUNG FUNCTION TEST; MALE; MULTICENTER STUDY; OXYGEN SATURATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SLEEP APNEA SYNDROME; SMOKING HABIT;

ADOLESCENT; ADULT; ASTHMA; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; NIGHT CARE; QUALITY OF LIFE; RESPIRATORY SYSTEM; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 33846910832     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00059706     Document Type: Article

References (26)

1. Janson C, Anto J, Burney P, et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 2001; 18: 598-611.
2. Health Canada. Respiratory Disease in Canada. Ottawa, Canada Lung Association, 2001.
3. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Eng J Med 1993; 328: 1230-1235.
4. Larsson LG, Lindberg A, Franklin KA, Lundbäck B. Symptoms related to obstructive sleep apnoea are common in subjects with asthma, chronic bronchitis and rhinitis in a general population. Respir Med 2001; 95: 423-429.
5. Ekici A, Ekici M, Kurtipek E, et al. Association of asthma-related symptons with snoring and apnea and effect on health-related quality of life. Chest 2005; 128: 3358-3363.
6. Jubber AS. Respiratory complications of obesity. Int J Clin Pract 2004; 58: 573-580.
7. Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol 1997; 99: 757S-762S.
8. Demeter P, Pap A. The relationship between gastroesophageal reflux disease and obstructive sleep apnea. J Gastroenterol 2004; 39: 815-820.
9. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003; 111: 1171-1183.
10. Cibella F, Cuttitta G. Nocturnal asthma and gastroesophageal reflux. Am J Med 2001; 111: 31S-36S.
11. Thomas PS, Geddes DM, Barnes PJ. Pseudo-steroid resistant asthma. Thorax 1999; 54: 352-356.
12. Yigla M, Tov N, Solomonov A, Rubin AH, Harlev D. Difficult-to-control asthma and obstructive sleep apnea. J Asthma 2003; 40: 865-871.
13. Hoffstein V, Viner S, Mateika S, Conway J. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Patient compliance, perception of benefits, and side effects. Am Rev Respir Dis 1992; 145: 841-845.
14. Guilleminault C, Quera-Salva MA, Powell N, et al. Nocturnal asthma: snoring, small pharynx and nasal CPAP. Eur Respir J 1988; 1: 902-907.
15. Chan CS, Woolcock AJ, Sullivan CE. Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis 1988; 137: 1502-1504.
16. Ciftci TU, Ciftci B, Guven SF, Kokturk O, Turktas H. Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome. Respir Med 2005; 99: 529-534.
17. Lin CC, Lin CY. Obstructive sleep apnea syndrome and bronchial hyperreactivity. Lung 1995; 173: 117-126.
18. Lin HC, Wang CH, Yang CT, et al. Effect of nasal continuous positive airway pressure on methacholine-induced bronchosconstriction. Respir Med 1995; 89: 121-128.
19. Wenzel G, Schonhofer B, Wenzel M, Kohler D. Bronchial hyperractivity and nCPAP therapy. Pneumologie 1997; 51: Suppl. 3, 770S-772S.
20. American Thoracic Society. Standards for the diagnosis of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
21. American Thoracic Society. Standardization of spirometry, 1994 Update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
22. Juniper EF, Cockcroft DW, Hargreave FE. Histamine and methacholine inhalation tests. 2nd Edn. Lund, Canadian Thoracic Society and Astra Draco AB, 1994.
23. An American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22: 667-689.
24. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76-83.
25. Lacasse Y, Bureau MP, Sériès F. A new standardized and self-administered quality of life questionnaire specific to obstructive sleep apnoea. Thorax 2004; 59: 494-499.
26. Collard P, Pieters T, Aubert G, Delguste P, Rodenstein DO. Compliance with nasal CPAP in obstructive sleep apnea patients. Sleep Med Rev 1997; 1: 33-44.